Pilot Study About Tamoxifen Therapy for Breast Cancer Patients

• Conditions: Breast Cancer

• Registration Number: NCT02094495
• Lead Sponsor: National Cancer Center, Korea

Brief Summary

The aim of this study are to to evaluate the knowledge and understanding on tamoxifen theraphy for breast cancer patients and examine the decision conflict scale and satisfaction with decision scale while making decision to take tamoxifen.

Detailed Description

The knowlege questionnaire about tamoxifen was developed by the medication guides that provide for patients taking tamoxifen and hormone therapy for breast cancer fact sheet from National Cancaer Institute. Several experts in the field of breast cancer and gynecologic cancer are going to review and indicate the questionnaire.

Study Timeline

• Study First Submitted: 2014-03-20
• Study First Submitted QC: 2014-03-20
• Study First Posted: 2014-03-21
• Status Verified: 2014-06
• Study Start: 2014-06
• Last Update Submitted: 2014-06-24
• Last Update Posted: 2014-06-26
• Primary Completion: 2017-03
• Study Completion: 2017-03

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Female
• Target Recruitment: 300

Inclusion Criteria

• The breast cancer patients who take tamoxifen

Exclusion Criteria

Exclusion criteria

• The patients who do not agree to participate in this study
• The paitents who have trouble with understanding and reading Korean.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The knowledge questionnaire about tamoxifen	The study outcome measure will be assessed by face-to-face, one time.	There are no more follow up except one time

Secondary Outcome Measures

Name	Time	Method
Decision Conflict Scale	The study outcome measure will be assessed by face-to-face , one time.	There are no more follow up except one time.

Trial Locations

Locations (1)

Center for Breast Cancer, National Cancer Center; 🇰🇷 Goyang-si, Gyeonggi-do, Korea, Republic of